Evaluation of Sex Hormones in Autoimmune Diseases in Pre- and Post-Menopausal Women
This retrospective study of 15,319 US women found that, with the exception of DHEA-s, there were no statistically significant differences in sex hormone levels between seropositive autoimmune subjects and seronegative controls across both pre- and post-menopausal groups.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Women are far more likely than men to develop autoimmune diseases, conditions where the body's immune system mistakenly turns against its own tissues. This imbalance is striking; in diseases like lupus, women outnumber men by nearly nine to one. For decades, scientists have suspected that sex hormones—the chemical messengers that drive reproduction and secondary sexual characteristics—might be the reason for this gap. The logic seemed sound: estrogen, the primary female hormone, is known to boost the immune system, while testosterone tends to calm it down. If the immune system is too strong, it might attack the body; if it is too weak, it might fail to fight infection. This led to a long-held theory that the very hormones that make women biologically distinct are also the ones making them vulnerable to these chronic illnesses.
To test this idea, researchers at Vibrant America Clinical Laboratory in California undertook a massive review of medical records. They looked at data from over 15,000 women who had their blood tested between 2015 and 2019. The goal was to see if women who carried high levels of autoantibodies—markers that signal the immune system is attacking the body—had different hormone levels compared to women who did not. The team divided the women into two main groups based on age: those under 50, who are generally still in their reproductive years, and those over 50, who have typically passed through menopause. They then compared the hormone levels of the women with autoimmune markers against those without, looking for any clear patterns that might explain the gender bias in these diseases.
The study examined a wide array of substances in the blood. On the immune side, they checked for thirteen different autoantibodies, including those linked to lupus, rheumatoid arthritis, and Sjögren's syndrome. On the hormonal side, they measured eleven different substances, ranging from estrogen and testosterone to cortisol and growth factors. The researchers expected to find that women with autoimmune markers would have significantly higher or lower levels of these hormones compared to healthy women. They also looked to see if the results changed after menopause, a time when hormone levels shift dramatically.
The results, however, were surprisingly quiet. When the researchers compared the hormone levels of women with autoimmune markers to those without, they found almost no difference. Whether the women were young or old, the levels of estrogen, testosterone, progesterone, and most other hormones were essentially the same in both groups. The only exception was a hormone called DHEA-S, an androgen produced by the adrenal glands. Women with autoimmune markers had slightly lower levels of this hormone than the control group, a finding that held true for both age groups. This small difference was statistically significant, but the study found no evidence that the other major hormones were driving the autoimmune response.
The researchers also looked at how common these autoimmune markers were in the general population. They found that about 30.8 percent of the women in the study had at least one autoantibody overall, though this prevalence varied by age, rising from 27.2 percent in women aged 20 to 50 to 35.7 percent in those over 50. Interestingly, the prevalence of hormonal imbalances was nearly identical in both age groups, suggesting that having an autoimmune marker does not necessarily mean a woman's hormones are out of whack. Even in women with specific conditions like rheumatoid arthritis, where the study observed an opposite tendency with higher median estradiol levels in seropositive subjects compared to controls, the overall conclusion remained that the correlation between hormones and disease appears indirect rather than a simple cause-and-effect relationship.
Ultimately, this large-scale study suggests that the link between sex hormones and autoimmune disease is not as direct as once thought. While hormones clearly play a role in how the immune system functions, the simple idea that women get these diseases because they have "too much" estrogen or "too little" testosterone does not hold up when looking at thousands of real-world cases. The data indicates that if hormones are involved, they are likely part of a much more complex web of factors involving genetics and environment, rather than a single chemical imbalance. The study confirms that for most women with these conditions, their hormone levels fall within the normal range, leaving scientists to look elsewhere for the true keys to understanding why autoimmune diseases target women so frequently.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.